Atlas Venture Fund XI, L.P.
CIK 0001708269 Name as filed on the most recent filing
Filed as Atlas Venture Fund XI, L.P. (13)
47 transaction lines · from 13 filings · filed 2019-06-25 to 2025-02-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Sionna Therapeutics, Inc. 1 filings
- ISSUER Dyne Therapeutics, Inc. 4 filings
- ISSUER Xilio Therapeutics, Inc. 3 filings
- ISSUER Third Harmonic Bio, Inc. 1 filings
- ISSUER Day One Biopharmaceuticals, Inc. 2 filings
- ISSUER Ikena Oncology, Inc. 1 filings
- ISSUER Akero Therapeutics, Inc. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-02-10 |
Sionna Therapeutics, Inc. SION |
P, Open-market purchase | 60,000 acquired | 18.00 | 1,080,000.00 | Form 4, filing 0000950170-25-017030 | |
| 2024-02-28 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 152,244 disposed | 24.83 | 3,780,218.52 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-28 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 22,567 disposed | 24.83 | 560,338.61 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-28 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 13,109 disposed | 24.83 | 325,496.47 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-28 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 2,430 disposed | 25.25 | 61,357.50 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-28 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 360 disposed | 25.25 | 9,090.00 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-28 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 210 disposed | 25.25 | 5,302.50 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-27 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 272,923 disposed | 24.38 | 6,653,862.74 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-27 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 40,455 disposed | 24.38 | 986,292.90 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-27 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 25,779 disposed | 24.68 | 636,225.72 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-27 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 23,505 disposed | 24.38 | 573,051.90 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-27 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 3,821 disposed | 24.68 | 94,302.28 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-27 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 2,216 disposed | 24.68 | 54,690.88 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-26 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 136,312 disposed | 23.59 | 3,215,600.08 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-26 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 64,783 disposed | 23.98 | 1,553,496.34 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-26 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 20,205 disposed | 23.59 | 476,635.95 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-26 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 11,736 disposed | 23.59 | 276,852.24 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-26 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 9,603 disposed | 23.98 | 230,279.94 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-26 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 5,580 disposed | 23.98 | 133,808.40 | Form 4, filing 0001415889-24-005777 | |
| 2024-02-23 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 159,542 disposed | 22.70 | 3,621,603.40 | Form 4, filing 0001415889-24-005124 | |
| 2024-02-23 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 23,648 disposed | 22.70 | 536,809.60 | Form 4, filing 0001415889-24-005124 | |
| 2024-02-23 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 13,738 disposed | 22.70 | 311,852.60 | Form 4, filing 0001415889-24-005124 | |
| 2024-02-22 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 119,360 disposed | 22.66 | 2,704,697.60 | Form 4, filing 0001415889-24-005124 | |
| 2024-02-21 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 149,337 disposed | 22.44 | 3,351,122.28 | Form 4, filing 0001415889-24-005124 | |
| 2024-02-21 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 35,164 disposed | 23.14 | 813,694.96 | Form 4, filing 0001415889-24-005124 | |
| 2024-02-20 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 166,029 disposed | 22.71 | 3,770,518.59 | Form 4, filing 0001415889-24-004467 | |
| 2024-02-20 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 3,510 disposed | 23.40 | 82,134.00 | Form 4, filing 0001415889-24-004467 | |
| 2024-02-16 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 162,707 disposed | 23.14 | 3,765,039.98 | Form 4, filing 0001415889-24-004467 | |
| 2024-02-15 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 175,793 disposed | 23.88 | 4,197,936.84 | Form 4, filing 0001415889-24-004467 | |
| 2024-02-15 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 2,113 disposed | 24.45 | 51,662.85 | Form 4, filing 0001415889-24-004467 | |
| 2024-02-08 |
Xilio Therapeutics, Inc. XLO |
S, Open-market sale | 733 disposed | 0.64 | 469.12 | Form 4, filing 0001209191-24-003031 | |
| 2024-02-08 |
Xilio Therapeutics, Inc. XLO |
S, Open-market sale | 267 disposed | 0.64 | 170.88 | Form 4, filing 0001209191-24-003031 | |
| 2024-01-12 |
Xilio Therapeutics, Inc. XLO |
S, Open-market sale | 1,540 disposed | 0.83 | 1,278.20 | Form 4, filing 0001209191-24-001655 | |
| 2024-01-12 |
Xilio Therapeutics, Inc. XLO |
S, Open-market sale | 560 disposed | 0.83 | 464.80 | Form 4, filing 0001209191-24-001655 | |
| 2024-01-11 |
Xilio Therapeutics, Inc. XLO |
S, Open-market sale | 1,566 disposed | 0.87 | 1,362.42 | Form 4, filing 0001209191-24-001655 | |
| 2024-01-11 |
Xilio Therapeutics, Inc. XLO |
S, Open-market sale | 569 disposed | 0.87 | 495.03 | Form 4, filing 0001209191-24-001655 | |
| 2022-12-12 |
Dyne Therapeutics, Inc. DYN |
P, Open-market purchase | 934,581 acquired | 10.70 | 10,000,016.70 | Form 4, filing 0001209191-22-061243 | |
| 2022-09-19 |
Third Harmonic Bio, Inc. THRD |
P, Open-market purchase | 300,000 acquired | 17.00 | 5,100,000.00 | Form 4, filing 0001209191-22-050535 | |
| 2022-06-17 |
Day One Biopharmaceuticals, Inc. DAWN |
P, Open-market purchase | 766,667 acquired | 15.00 | 11,500,005.00 | Form 4, filing 0001209191-22-038713 | |
| 2021-12-14 |
Ikena Oncology, Inc. IKNA |
S, Open-market sale | 5,959 disposed | 14.00 | 83,426.00 | Form 4, filing 0001209191-21-069644 | |
| 2021-12-13 |
Ikena Oncology, Inc. IKNA |
S, Open-market sale | 8,330 disposed | 14.64 | 121,951.20 | Form 4, filing 0001209191-21-069644 | |
| 2021-12-10 |
Ikena Oncology, Inc. IKNA |
S, Open-market sale | 11,989 disposed | 15.03 | 180,194.67 | Form 4, filing 0001209191-21-069644 | |
| 2021-10-26 |
Xilio Therapeutics, Inc. XLO |
P, Open-market purchase | 187,500 acquired | 16.00 | 3,000,000.00 | Form 4, filing 0001104659-21-130026 | |
| 2021-06-01 |
Day One Biopharmaceuticals, Inc. DAWN |
P, Open-market purchase | 250,000 acquired | 16.00 | 4,000,000.00 | Form 4, filing 0001209191-21-037402 | |
| 2021-06-01 |
Day One Biopharmaceuticals, Inc. DAWN |
P, Open-market purchase | 250,000 acquired | 16.00 | 4,000,000.00 | Form 4, filing 0001209191-21-037402 | |
| 2021-03-30 |
Ikena Oncology, Inc. IKNA |
P, Open-market purchase | 125,000 acquired | 16.00 | 2,000,000.00 | Form 4, filing 0001209191-21-069644 | |
| 2019-06-24 |
Akero Therapeutics, Inc. AKRO |
P, Open-market purchase | 270,000 acquired | 16.00 | 4,320,000.00 | Form 4, filing 0001104659-19-037461 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Atlas Venture Fund XI, L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001708269
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6